What is H.C. Wainwright's price target for ALIM?

H.C. Wainwright's latest stated price target for Alimera Sciences Inc. (ALIM) is $10, from its action on Feb 25, 2022.

What is H.C. Wainwright's rating on ALIM?

H.C. Wainwright rates ALIM Neutral, a neutral rating, as of Jun 25, 2024.

When did H.C. Wainwright last change its view on ALIM?

On Jun 25, 2024, H.C. Wainwright downgrades to Neutral from Buy.

H.C. Wainwright ALIM price target and rating history

Alimera Sciences Inc. (ALIM) · Health Care

H.C. Wainwright rates Alimera Sciences Inc. (ALIM) Neutral with a $10 price target, as of its latest action on Jun 25, 2024. It has published 3 rating actions on ALIM since August 2021, including 0 upgrades and 1 downgrade.

Current rating: Neutral
Price target: $10
Median target, all firms: Too few
Actions on ALIM: 3

H.C. Wainwright price target on ALIM

H.C. Wainwright price target on ALIM, each point a stated target, August 2021 to February 2022.

Every H.C. Wainwright rating on ALIM

Jun 25, 2024
DowngradeH.C. Wainwright downgrades to Neutral from Buy
Feb 25, 2022
ReiterateH.C. Wainwright cuts its price target to $10 from $12, keeps Buy
Aug 16, 2021
ReiterateH.C. Wainwright cuts its price target to $12 from $16, keeps Buy

Questions about H.C. Wainwright and ALIM

What is H.C. Wainwright's price target for ALIM?: H.C. Wainwright's latest stated price target for Alimera Sciences Inc. (ALIM) is $10, from its action on Feb 25, 2022.
What is H.C. Wainwright's rating on ALIM?: H.C. Wainwright rates ALIM Neutral, a neutral rating, as of Jun 25, 2024.
When did H.C. Wainwright last change its view on ALIM?: On Jun 25, 2024, H.C. Wainwright downgrades to Neutral from Buy.

All H.C. Wainwright ratings ALIM news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.